After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ROIV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Roivant Sciences Ltd is $9.37B. A total of 3.59 million shares were traded on the day, compared to an average of 7.38M shares.
In the most recent transaction, Venker Eric sold 96,950 shares of ROIV for 10.92 per share on Feb 09 ’24. After the transaction, the President & COO now owns 532,207 company shares. In a previous transaction on Jan 02 ’24, Ramaswamy Vivek sold 3,000,000 shares at 11.05 per share. ROIV shares that 10% Owner owns now total 51,929,426.
Among the insiders who sold shares, Venker Eric disposed of 153,027 shares on Oct 05 ’23 at a per-share price of $10.11. This resulted in the Chief Operating Officer holding 595,397 shares of ROIV after the transaction. In another insider transaction, Venker Eric sold 606,221 shares at $10.25 per share on Oct 03 ’23. Company shares held by the Chief Operating Officer now total 595,397.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ROIV has a high of $13.24 and a low of $7.01.
As of this writing, ROIV has an earnings estimate of -$0.3 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.24 per share and a lower estimate of -$0.37. The company reported an EPS of -$0.4 in the last quarter, which was -29.00% lower than expectations of -$0.31.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ROIV’s latest balance sheet shows that the firm has $2.06B in Cash & Short Term Investments as of fiscal 2022. There were $283.89M in debt and $184.37M in liabilities at the time. Its Book Value Per Share was $7.57, while its Total Shareholder’s Equity was $2.06B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ROIV is Buy with a score of 4.85.
